COMMUNIQUÉS West-GlobeNewswire

Teligent, Inc. Announces Second Quarter 2019 Results

05/08/2019 - 22:15

BUENA, N.J., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2019 [...]

Bellicum Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Operational Update

05/08/2019 - 22:15

Interim safety and activity data for BPX-601 presented at American Society of Clinical Oncology (ASCO) Annual Meeting Rivo-cel TM achieved primary endpoint in BP-004 European registrational trial HOUSTON, Aug. 05, 2019 [...]

OrthoPediatrics Corp. to Participate in 4th Annual Needham Med Tech & Diagnostics Conference

05/08/2019 - 22:05

WARSAW, Ind., Aug. 05, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that Mark Throdahl [...]

Fulgent Genetics Reports Second Quarter 2019 Financial Results

05/08/2019 - 22:05

Second Quarter 2019 Results : Record billable tests of 16,369, growing 187% year over year Record revenue of $8.4 million, growing 56% year over year Gross Margin improves more than 12 percentage points sequentially; [...]

GenMark Diagnostics Reports Second Quarter 2019 Results

05/08/2019 - 22:05

CARLSBAD, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]

Assembly Biosciences Reports Second Quarter 2019 Financial Results and Recent Highlights

05/08/2019 - 22:05

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and [...]

Diversicare Announces 2019 Second Quarter Results

05/08/2019 - 22:05

BRENTWOOD, Tenn., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced its results for the second quarter ended June 30, [...]

Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu

05/08/2019 - 22:05

Clinical trial expected to initiate in the fall of 2019 GAITHERSBURG, Md., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for [...]

ChemoCentryx Reports Second Quarter 2019 Financial Results and Recent Highlights

05/08/2019 - 22:05

-- Topline data from pivotal ADVOCATE Phase III trial of C5a receptor inhibitor avacopan in ANCA Vasculitis on track for Q4 2019 -- -- Completed enrollment in LUMINA 1 Phase II trial of CCR2 inhibitor CCX140 in Focal [...]

Harpoon Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

05/08/2019 - 22:05

Continued enrollment and dose escalation of Phase 1 trial for HPN424, Harpoon’s lead TriTAC product candidate in development for the treatment of prostate cancer Initiated Phase 1/2a clinical trial for HPN536, Harpoon’s [...]

Shockwave Medical Reports Second Quarter 2019 Financial Results

05/08/2019 - 22:03

SANTA CLARA, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]

Entasis Therapeutics Appoints Dr. Howard Mayer to Board of Directors

05/08/2019 - 22:01

WALTHAM, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]

Radius Health Initiates Phase 3 wearABLe Study of Abaloparatide-Patch in Postmenopausal Osteoporosis Patients at High Risk for Fracture

05/08/2019 - 22:00

Abaloparatide-Patch patient assessment study results demonstrated high patient acceptability and self-administration accuracy over a 29-day period Levels of PINP, a biomarker for bone formation, after one month in [...]

United Health Products Announces the Completion of Human Trial Surgery Enrollment

05/08/2019 - 21:54

HENDERSON, Nev., Aug. 05, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound [...]

Opthea to Host Investor Teleconference

05/08/2019 - 19:08

MELBOURNE, Australia, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT) will host a conference call to discuss the results of the Company’s Phase 2b clinical trial of OPT-302 in combination with Lucentis ® ( [...]

Major shareholder announcement

05/08/2019 - 18:20

Company announcement No. 24/2019 Orphazyme A/S Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 Copenhagen, August 5, 2019 – Orphazyme A/S, a biopharmaceutical company dedicated [...]

Corizon Health Chosen to Continue Services for Fayette County, Kentucky

05/08/2019 - 18:14

BRENTWOOD, Tenn., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Corizon Health recently won a competitive bidding process to continue providing medical services for offenders in the Community Corrections Center operated by the [...]

Dr. Gary Kaplan to Present Keynote at The Governance Institute’s October Leadership Conference

05/08/2019 - 18:10

Influential physician executive and healthcare leader will challenge boards with improving quality, safety, and efficiency LINCOLN, Neb., Aug. 05, 2019 (GLOBE NEWSWIRE) -- The Governance Institute , a service of NRC [...]

BioTelemetry, Inc. Names Manish Wadhwa, M.D., F.H.R.S. Chief Medical Officer

05/08/2019 - 18:07

MALVERN, Pa., Aug. 05, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of [...]